id	sid	tid	token	lemma	pos
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	1	PIN24	PIN24	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	2	THE	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	3	ECONOMIC	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	4	IMPACT	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	5	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	6	METHICILLIN	METHICILLIN	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	7	RESISTANCE	RESISTANCE	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	8	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	9	STAPHYLOCOCCUS	STAPHYLOCOCCUS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	10	AUREUS	AUREUS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	11	BACTEREMIA	BACTEREMIA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	12	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	13	KOREA	KOREA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	14	A166	A166	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	15	Abstracts	Abstracts	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	16	parison	parison	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	17	purposes	purpose	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	18	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	19	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	20	mortality	mortality	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	21	rate	rate	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	22	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	23	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	24	inpatients	inpatient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	25	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	26	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	27	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	28	infections	infection	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	29	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	30	7.3	7.3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	31	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	1	32	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	1	Patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	2	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	3	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	4	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	5	cSSSIs	csssis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	6	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	7	older	old	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	8	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	9	mean	mean	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	10	age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	11	54	54	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	12	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	13	vs.	vs.	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	14	46	46	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	15	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	16	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	17	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	18	comparison	comparison	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	19	group	group	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	20	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	21	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	22	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	23	more	more	RBR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	24	likely	likely	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	25	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	26	have	have	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	27	congestive	congestive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	28	heart	heart	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	29	failure	failure	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	30	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	31	diabetes	diabete	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	32	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	33	chronic	chronic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	34	complications	complication	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	35	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	36	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	37	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	38	septicemia	septicemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	2	39	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	1	Relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	2	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	3	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	4	comparison	comparison	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	5	group	group	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	6	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	7	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	8	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	9	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	10	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	11	cSSSIs	csssis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	12	had	have	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	13	significantly	significantly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	14	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	15	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	16	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	17	0.0001	0.0001	LS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	18	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	19	longer	longer	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	20	mean	mean	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	21	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	22	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	23	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	24	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	25	9.7	9.7	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	26	vs.	vs.	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	27	4.4	4.4	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	28	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	29	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	30	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	31	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	32	average	average	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	33	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	34	per	per	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	35	stay	stay	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	36	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	37	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	38	16,941	16,941	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	39	vs.	vs.	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	40	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	41	9,154	9,154	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	42	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	3	43	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	1	After	after	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	2	con-	con-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	3	trolling	troll	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	4	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	5	potentially	potentially	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	6	confounding	confound	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	7	factors	factor	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	8	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	9	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	10	excess	excess	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	11	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	12	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	13	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	14	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	15	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	16	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	17	cSSSIs	csssis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	18	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	19	estimated	estimate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	20	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	21	be	be	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	22	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	23	3,396	3,396	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	4	24	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	1	CONCLUSION	conclusion	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	3	Our	-PRON-	PRP$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	4	findings	finding	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	5	suggest	suggest	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	6	that	that	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	7	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	8	clinical	clinical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	9	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	10	eco-	eco-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	11	nomic	nomic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	12	burden	burden	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	13	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	14	complicated	complicated	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	15	skin	skin	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	16	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	17	skin	skin	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	18	structure	structure	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	19	infections	infection	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	20	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	21	cSSSIs	csssis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	22	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	23	due	due	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	24	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	25	Staphylococcus	Staphylococcus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	26	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	27	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	28	hospitalized	hospitalized	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	29	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	30	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	31	substantial	substantial	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	5	32	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	1	PIN22	PIN22	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	2	IMPACT	IMPACT	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	3	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	4	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	5	AUREUS	AUREUS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	6	INFECTIONS	infection	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	7	ON	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	8	EXPENDITURES	EXPENDITURES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	9	AND	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	10	LENGTH	LENGTH	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	11	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	12	OF	OF	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	13	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	14	STAY	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	15	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	6	16	U.S.	U.S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	1	HOSPITALS	HOSPITALS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	2	Noskin	Noskin	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	3	G1	G1	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	4	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	5	Rubin	Rubin	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	6	R2	R2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	7	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	8	Schentag	Schentag	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	9	J3	J3	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	10	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	11	Kluytmans	Kluytmans	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	12	J4	J4	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	14	Hedblom	Hedblom	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	15	E5	e5	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	17	Jacobson	Jacobson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	18	C5	C5	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	20	Smulders	Smulders	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	21	M6	M6	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	23	Gemmen	Gemmen	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	24	EK7	EK7	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	25	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	26	Bharmal	Bharmal	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	27	M7	M7	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	28	1Northwestern	1Northwestern	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	29	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	30	Feinberg	Feinberg	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	31	School	School	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	32	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	33	Medicine	Medicine	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	34	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	35	Chicago	Chicago	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	37	IL	IL	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	38	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	39	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	40	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	41	2Georgetown	2Georgetown	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	42	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	43	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	44	Washington	Washington	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	45	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	46	DC	DC	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	47	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	48	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	49	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	50	3University	3University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	51	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	52	Buffalo	Buffalo	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	53	School	School	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	54	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	55	Pharmacy	Pharmacy	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	56	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	57	Buffalo	Buffalo	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	58	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	59	NY	NY	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	60	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	61	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	62	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	63	4Amphia	4Amphia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	64	Hospital	Hospital	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	65	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	66	VUmc	VUmc	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	67	Medical	Medical	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	68	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	69	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	70	Amsterdam	Amsterdam	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	71	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	72	4800	4800	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	73	RK	RK	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	74	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	75	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	76	Netherlands	Netherlands	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	77	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	78	53	53	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	79	M	M	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	80	Medical	Medical	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	81	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	82	St	St	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	83	Paul	Paul	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	84	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	85	MN	MN	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	86	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	87	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	88	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	89	6Quintiles	6Quintiles	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	90	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	91	Falls	Falls	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	92	Church	Church	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	93	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	94	VA	VA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	95	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	96	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	97	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	98	7Quintiles	7Quintiles	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	99	Strategic	Strategic	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	100	Research	Research	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	101	&	&	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	102	Safety	Safety	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	103	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	104	Falls	Falls	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	105	Church	Church	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	106	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	107	VA	VA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	108	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	109	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	110	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	111	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	112	Evaluate	evaluate	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	113	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	114	incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	115	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	116	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	117	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	118	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	119	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	120	stays	stay	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	121	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	122	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	123	charges	charge	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	124	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	125	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	126	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	127	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	128	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	129	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	130	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	131	U.S.	U.S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	132	hospitals	hospital	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	133	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	134	2003	2003	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	7	135	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	1	METHODS	METHODS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	3	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	4	2003	2003	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	5	Nationwide	Nationwide	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	6	Inpatient	Inpatient	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	7	Sample	Sample	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	8	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	9	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	10	analyzed	analyze	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	8	11	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	1	Hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	2	discharges	discharge	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	4	classified	classify	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	5	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	6	either	either	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	7	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	8	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	9	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	10	–	–	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	11	related	related	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	12	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	13	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	14	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	15	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	16	non	non	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	17	-	-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	18	S.	s.	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	19	aureus-	aureus-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	20	related	related	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	21	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	22	stay	stay	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	23	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	24	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	25	combination	combination	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	26	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	27	several	several	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	28	ICD-9	ICD-9	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	29	codes	code	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	9	30	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	1	Incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	2	effect	effect	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	3	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	4	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	5	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	6	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	7	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	8	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	9	charges	charge	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	10	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	11	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	12	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	13	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	14	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	15	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	16	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	17	estimated	estimate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	18	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	19	multivariate	multivariate	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	20	regression	regression	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	21	models	model	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	22	adjusting	adjust	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	23	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	24	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	25	fixed	fix	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	26	effects	effect	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	27	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	28	patient	patient	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	29	variables	variable	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	30	including	include	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	31	age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	32	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	33	gender	gender	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	34	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	35	race	race	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	37	payer	payer	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	38	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	39	diagnosis	diagnosis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	40	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	41	related	relate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	42	grouping	grouping	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	43	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	44	concomitant	concomitant	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	45	conditions	condition	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	46	including	include	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	47	diabetes	diabetes	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	48	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	49	dialy-	dialy-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	50	sis	sis	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	51	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	52	lung	lung	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	53	disease	disease	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	10	54	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	3	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	4	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	5	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	6	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	7	reported	report	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	8	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	9	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	10	discharge	discharge	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	11	diagnosis	diagnosis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	12	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	13	1.0	1.0	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	14	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	15	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	16	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	17	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	18	inpatients	inpatient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	20	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	21	389,963	389,963	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	22	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	23	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	24	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	25	2003	2003	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	11	26	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	1	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	2	aureus	aureus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	3	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	4	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	5	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	6	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	7	significantly	significantly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	8	more	more	RBR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	9	likely	likely	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	10	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	11	male	male	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	12	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	13	older	old	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	14	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	15	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	16	stays	stay	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	17	that	that	WDT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	18	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	19	paid	pay	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	20	by	by	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	21	Medicare	Medicare	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	23	white	white	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	24	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	25	non	non	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	26	-	-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	27	Hispanics	Hispanics	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	28	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	29	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	30	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	31	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	32	individuals	individual	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	33	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	34	diabetes	diabetes	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	35	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	36	lung	lung	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	37	disease	disease	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	38	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	39	dialysis	dialysis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	12	40	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	1	After	after	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	2	adjusting	adjust	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	3	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	4	covariates	covariate	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	5	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	6	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	7	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	8	incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	9	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	11	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	12	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	13	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	14	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	15	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	16	charges	charge	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	17	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	18	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	19	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	20	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	21	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	22	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	23	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	24	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	25	37,251	37,251	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	26	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	27	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	28	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	29	Confidence	Confidence	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	30	Interval	Interval	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	31	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	32	CI	CI	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	33	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	34	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	35	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	36	34,678–$39,823	34,678–$39,823	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	37	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	38	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	39	8.2	8.2	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	40	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	41	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	42	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	43	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	44	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	45	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	46	7.9–8.5	7.9–8.5	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	47	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	48	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	49	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	50	inpatient	inpatient	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	51	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	52	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	53	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	54	40,637	40,637	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	55	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	56	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	57	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	58	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	59	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	60	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	61	37,683–$43,591	37,683–$43,591	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	62	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	63	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	64	9.2	9.2	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	65	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	66	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	67	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	68	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	69	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	70	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	71	8.8–9.6	8.8–9.6	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	72	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	73	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	74	surgical	surgical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	75	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	76	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	77	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	78	83,952	83,952	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	79	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	80	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	81	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	82	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	83	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	84	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	85	75,853–$92,052	75,853–$92,052	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	86	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	87	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	88	16.8	16.8	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	89	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	90	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	91	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	92	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	93	CI:15.7–17.9	ci:15.7–17.9	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	94	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	95	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	96	invasive	invasive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	97	cardiovascular	cardiovascular	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	98	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	99	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	100	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	101	34,202	34,202	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	102	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	103	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	104	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	105	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	106	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	107	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	108	29,612–$38,791	29,612–$38,791	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	109	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	110	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	111	9.6	9.6	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	112	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	113	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	114	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	115	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	116	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	117	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	118	9.0–10.2	9.0–10.2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	119	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	120	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	121	invasive	invasive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	122	orthopedic	orthopedic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	123	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	124	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	125	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	126	119,292	119,292	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	127	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	128	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	129	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	130	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	131	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	132	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	133	106,209–$132,374	106,209–$132,374	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	134	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	135	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	136	19.8	19.8	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	137	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	138	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	139	95	95	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	140	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	141	CI	ci	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	142	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	143	17.5–22.2	17.5–22.2	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	144	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	145	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	146	invasive	invasive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	147	neurosurgical	neurosurgical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	148	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	13	149	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	1	CONCLUSION	CONCLUSION	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	3	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	4	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	5	infections	infection	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	6	present	present	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	7	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	8	considerable	considerable	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	9	economic	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	10	burden	burden	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	11	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	12	U.S	U.S	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	13	hospitals	hospital	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	14	14	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	1	Based	base	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	2	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	3	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	4	prevalence	prevalence	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	5	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	6	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	7	aureus	aureus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	8	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	9	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	10	its	-PRON-	PRP$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	11	incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	12	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	14	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	15	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	16	economic	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	17	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	18	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	19	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	20	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	21	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	22	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	23	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	24	admissions	admission	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	25	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	26	estimated	estimate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	27	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	28	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	29	14.5	14.5	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	30	billion	billion	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	31	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	32	2004	2004	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	33	U.S.	U.S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	34	dollars	dollar	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	15	35	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	1	PIN23	PIN23	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	2	DETERMINANTS	determinant	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	3	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	4	TOTAL	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	5	HOSPITAL	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	6	COSTS	costs	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	7	AMONG	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	8	INPATIENTS	inpatient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	9	WITH	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	10	CANDIDEMIA	CANDIDEMIA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	11	Lee	Lee	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	12	SP1	SP1	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	14	Bunz	Bunz	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	15	T2	t2	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	17	Gagne	Gagne	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	18	JJ2	JJ2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	20	Maio	Maio	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	21	V2	V2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	23	Goldfarb	Goldfarb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	24	NI2	NI2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	25	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	26	Horn	Horn	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	27	DL2	DL2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	28	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	29	Swanson	Swanson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	30	R3	R3	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	31	1Thomas	1Thomas	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	32	Jefferson	Jefferson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	33	Univeristy	Univeristy	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	34	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	35	Philadelphia	Philadelphia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	37	PA	PA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	38	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	39	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	40	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	41	2Thomas	2Thomas	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	42	Jefferson	Jefferson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	43	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	44	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	45	Philadelphia	Philadelphia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	46	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	47	PA	PA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	48	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	49	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	50	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	51	3Pfizer	3Pfizer	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	52	Inc	Inc	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	53	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	54	New	New	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	55	York	York	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	56	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	57	NY	NY	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	58	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	59	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	60	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	61	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	62	To	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	63	identify	identify	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	64	factors	factor	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	65	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	66	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	67	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	68	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	69	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	70	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	71	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	72	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	73	candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	74	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	75	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	76	large	large	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	77	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	78	urban	urban	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	79	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	80	tertiary	tertiary	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	81	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	82	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	83	teaching	teaching	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	84	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	16	85	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	1	METHODS	methods	LS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	3	This	this	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	4	retrospective	retrospective	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	5	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	6	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	7	examined	examine	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	8	hospitalizations	hospitalization	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	9	during	during	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	10	calendar	calendar	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	11	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	12	2004	2004	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	13	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	14	2005	2005	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	15	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	16	Thomas	Thomas	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	17	Jefferson	Jefferson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	18	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	19	Hospital	Hospital	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	20	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	21	Philadelphia	Philadelphia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	23	PA	PA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	24	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	25	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	26	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	27	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	28	various	various	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	29	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	30	systems	system	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	17	31	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	1	Candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	2	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	4	identified	identify	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	5	via	via	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	6	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	7	microbiological	microbiological	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	8	laboratory	laboratory	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	9	information	information	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	10	system	system	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	11	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	12	those	those	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	13	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	14	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	15	at	at	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	16	least	least	RBS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	17	one	one	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	18	confirmed	confirm	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	19	positive	positive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	20	blood	blood	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	21	culture	culture	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	22	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	23	any	any	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	24	Candida	Candida	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	25	species	specie	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	26	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	27	any	any	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	28	point	point	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	29	during	during	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	30	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	31	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	32	period	period	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	18	33	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	1	Demographic	demographic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	2	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	3	economic	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	4	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	5	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	6	clinical	clinical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	7	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	8	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	9	includ-	includ-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	10	ing	ing	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	11	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	12	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	13	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	14	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	15	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	16	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	17	LOS	LOS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	18	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	20	payer	payer	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	21	types	type	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	23	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	24	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	25	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	26	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	27	Diagnosis	Diagnosis	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	28	Related	Related	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	29	Group	Group	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	30	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	31	DRG	DRG	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	32	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	33	assignments	assignment	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	34	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	35	collected	collect	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	36	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	37	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	38	hos-	hos-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	39	pital	pital	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	40	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	41	accounting	accounting	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	42	system	system	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	19	43	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	20	1	Pharmacy	pharmacy	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	20	2	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	20	3	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	20	4	i.e.	i.e.	FW
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	1	medications	medication	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	2	administered	administer	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	3	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	4	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	5	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	6	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	7	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	8	retrieved	retrieve	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	9	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	10	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	11	phar-	phar-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	12	macy	macy	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	13	electronic	electronic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	14	information	information	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	15	system	system	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	21	16	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	1	A	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	2	multivariate	multivariate	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	3	regression	regression	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	4	analysis	analysis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	5	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	6	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	7	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	8	natural	natural	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	9	logarithm	logarithm	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	11	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	12	hospitalization	hospitalization	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	13	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	14	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	15	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	16	dependent	dependent	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	17	variable	variable	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	18	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	19	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	20	conducted	conduct	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	22	21	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	1	Independent	independent	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	2	variables	variable	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	3	included	include	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	4	demographic	demographic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	5	information	information	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	6	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	7	relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	8	DRG	DRG	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	9	weights	weight	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	10	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	11	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	12	Candida	Candida	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	13	species	specie	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	23	14	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	3	Among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	4	68,526	68,526	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	5	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	6	hospitalizations	hospitalization	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	7	during	during	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	8	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	9	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	10	period	period	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	11	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	12	287	287	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	13	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	14	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	15	con-	con-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	16	firmed	firm	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	17	positive	positive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	18	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	19	candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	24	20	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	2	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	3	age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	4	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	5	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	6	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	7	58	58	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	8	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	9	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	10	52	52	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	11	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	12	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	13	female	female	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	14	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	15	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	16	60	60	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	17	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	18	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	19	Caucasian	caucasian	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	25	20	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	2	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	3	LOS	LOS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	4	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	5	43.3	43.3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	6	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	7	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	8	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	9	average	average	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	10	inpatient	inpatient	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	11	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	12	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	13	candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	14	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	15	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	16	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	17	130,759	130,759	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	18	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	19	SD	SD	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	20	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	21	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	22	116,560	116,560	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	23	;	;	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	24	median	median	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	25	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	26	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	27	97,869	97,869	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	28	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	26	29	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	2	most	most	RBS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	3	common	common	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	4	Candida	Candida	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	5	species	specie	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	6	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	7	C.	C.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	8	albicans	albicans	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	9	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	10	n	n	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	11	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	12	127	127	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	13	;	;	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	14	44	44	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	15	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	16	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	27	17	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	2	most	most	RBS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	3	commonly	commonly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	4	used	use	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	5	antifungal	antifungal	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	6	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	7	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	8	fluconazole	fluconazole	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	9	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	10	N	n	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	11	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	12	176	176	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	14	61	61	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	15	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	16	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	28	17	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	1	Age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	2	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	3	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	4	relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	5	DRG	drg	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	6	weights	weight	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	7	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	8	p	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	9	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	10	0.05	0.05	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	11	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	12	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	13	significantly	significantly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	14	positively	positively	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	15	correlated	correlate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	16	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	17	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	18	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	19	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	29	20	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	1	Older	old	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	2	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	3	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	4	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	5	relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	6	DRG	DRG	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	7	weights	weight	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	8	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	9	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	10	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	11	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	12	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	13	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	14	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	30	15	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	1	Race	race	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	2	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	3	gender	gender	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	4	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	5	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	6	marital	marital	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	7	status	status	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	8	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	9	not	not	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	10	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	11	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	12	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	13	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	31	14	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	1	CONCLUSION	conclusion	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	3	Relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	4	DRG	DRG	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	5	weights	weight	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	6	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	7	as	as	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	8	well	well	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	9	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	10	age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	11	are	be	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	12	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	13	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	14	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	15	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	16	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	17	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	18	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	19	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	20	candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	32	21	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	1	Candidemia	candidemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	2	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	3	expensive	expensive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	4	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	5	treat	treat	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	6	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	7	results	result	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	8	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	9	lengthy	lengthy	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	10	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	11	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	33	12	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	1	Early	early	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	2	detection	detection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	3	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	4	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	5	may	may	MD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	6	significantly	significantly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	7	reduce	reduce	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	8	resource	resource	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	9	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	10	as	as	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	11	well	well	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	12	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	13	improve	improve	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	14	outcomes	outcome	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	34	15	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	1	PIN24	PIN24	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	2	THE	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	3	ECONOMIC	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	4	IMPACT	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	5	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	6	METHICILLIN	METHICILLIN	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	7	RESISTANCE	RESISTANCE	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	8	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	9	STAPHYLOCOCCUS	STAPHYLOCOCCUS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	10	AUREUS	AUREUS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	11	BACTEREMIA	BACTEREMIA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	12	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	13	KOREA	KOREA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	14	Park	Park	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	15	EJ1	EJ1	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	17	Lee	Lee	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	18	EK2	EK2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	20	Chae	Chae	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	21	S3	S3	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	22	1Korea	1Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	23	Institute	Institute	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	24	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	25	Health	Health	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	26	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	27	Social	Social	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	28	Afffairs	Afffairs	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	29	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	30	Seoul	Seoul	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	31	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	32	South	South	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	33	Korea	Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	34	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	35	2Sookmyung	2Sookmyung	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	36	Women	Women	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	37	’s	’s	POS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	38	University	University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	39	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	40	Seoul	Seoul	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	41	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	42	South	South	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	43	Korea	Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	44	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	45	3Korea	3Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	46	Institute	Institute	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	47	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	48	Health	Health	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	49	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	50	Social	Social	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	51	Affairs	Affairs	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	52	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	53	Seoul	Seoul	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	54	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	55	South	South	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	56	Korea	Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	57	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	58	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	59	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	60	objective	objective	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	61	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	62	this	this	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	63	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	64	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	65	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	66	examine	examine	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	67	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	68	eco-	eco-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	69	nomic	nomic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	70	outcome	outcome	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	71	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	72	Methicillin	Methicillin	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	73	resistance	resistance	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	74	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	75	Staphylococcus	Staphylococcus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	76	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	77	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	78	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	79	Korea	Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	80	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	81	where	where	WRB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	82	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	83	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	84	endemic	endemic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	85	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	86	major-	major-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	87	ity	ity	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	88	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	89	hospitals	hospital	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	35	90	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	1	METHODS	methods	LS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	3	We	-PRON-	PRP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	4	conducted	conduct	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	5	retrospective	retrospective	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	6	case-	case-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	7	control	control	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	8	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	9	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	10	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	11	admitted	admit	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	12	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	13	three	three	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	14	university	university	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	15	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	16	based	base	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	17	teaching	teaching	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	18	hospitals	hospital	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	19	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	20	Seoul	Seoul	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	21	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	22	Korea	Korea	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	23	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	24	2005	2005	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	36	25	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	1	Cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	2	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	3	defined	define	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	4	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	5	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	6	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	7	Methicillin	Methicillin	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	8	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	9	resistant	resistant	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	10	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	11	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	12	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	13	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	14	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	15	bac-	bac-	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	16	teremia	teremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	17	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	18	controls	control	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	19	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	20	Methicillin-	Methicillin-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	21	susceptible	susceptible	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	22	S.	S.	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	23	aureus	aureus	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	24	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	25	MSSA	MSSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	26	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	27	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	28	selected	select	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	29	according	accord	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	30	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	31	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	32	priori	priori	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	33	matching	matching	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	34	cri-	cri-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	35	teria	teria	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	37	36	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	1	58	58	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	2	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	3	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	4	58	58	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	5	controls	control	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	6	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	7	identified	identify	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	38	8	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	1	Hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	2	charges	charge	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	4	collected	collect	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	5	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	6	hospitals	hospital	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	7	’	’	POS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	8	billing	billing	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	9	system	system	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	39	10	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	3	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	4	median	median	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	5	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	6	charge	charge	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	7	after	after	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	8	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	9	development	development	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	11	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	12	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	13	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	14	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	15	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	16	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	17	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	18	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	19	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	20	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	21	8245	8245	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	22	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	23	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	24	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	25	con-	con-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	26	trols	trol	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	27	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	28	MSSA	MSSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	29	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	30	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	31	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	32	6569	6569	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	33	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	40	34	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	2	median	median	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	3	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	4	A167Abstracts	a167abstract	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	5	charge	charge	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	6	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	7	pharmaceuticals	pharmaceutical	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	8	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	9	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	10	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	11	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	12	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	13	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	14	2411	2411	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	15	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	16	that	that	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	17	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	18	MSSA	mssa	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	19	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	20	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	21	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	22	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	23	1289	1289	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	41	24	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	2	median	median	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	3	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	4	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	5	hospitalization	hospitalization	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	6	after	after	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	7	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	8	development	development	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	9	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	10	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	11	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	12	who	who	WP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	13	survived	survive	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	14	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	15	32.5	32.5	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	16	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	17	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	18	that	that	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	19	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	20	MSSA	MSSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	21	bac-	bac-	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	22	teremia	teremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	23	control	control	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	24	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	25	who	who	WP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	26	survived	survive	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	27	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	28	18	18	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	29	days	day	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	42	30	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	1	CONCLU-	CONCLU-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	2	SION	SION	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	3	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	4	Antibiotic	antibiotic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	5	resistance	resistance	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	6	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	7	Staphylococcus	Staphylococcus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	8	aureus	aureus	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	9	bacteremia	bacteremia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	10	increased	increase	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	11	direct	direct	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	12	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	13	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	14	by	by	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	15	26	26	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	16	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	43	17	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	2	results	result	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	3	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	4	this	this	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	5	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	6	indicate	indicate	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	7	that	that	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	8	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	9	MRSA	MRSA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	10	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	11	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	12	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	13	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	14	increased	increase	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	15	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	16	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	17	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	18	prolonged	prolonged	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	19	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	20	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	44	21	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	1	PIN25	pin25	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	2	DIRECT	direct	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	3	COSTS	costs	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	4	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	5	ANEMIA	ANEMIA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	6	AMONG	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	7	PATIENTS	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	8	TREATED	treated	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	9	WITH	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	10	ZIDOVUDINE	ZIDOVUDINE	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	11	Curkendall	Curkendall	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	12	S1	S1	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	14	Doan	Doan	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	15	QV2	QV2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	17	Everhard	Everhard	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	18	F3	F3	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	19	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	20	Richardson	Richardson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	21	J1	J1	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	23	Emons	Emons	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	24	MF2	MF2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	25	1Cerner	1Cerner	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	26	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	27	Vienna	Vienna	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	28	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	29	VA	VA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	30	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	31	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	32	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	33	2Cerner	2Cerner	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	34	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	35	Beverly	Beverly	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	36	Hills	Hills	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	37	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	38	CA	CA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	39	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	40	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	41	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	42	3Gilead	3Gilead	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	43	Sciences	Sciences	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	44	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	45	Foster	Foster	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	46	City	City	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	47	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	48	CA	CA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	49	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	50	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	51	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	52	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	53	Zidovudine	Zidovudine	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	54	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	55	ZDV	ZDV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	56	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	57	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	58	has	have	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	59	been	be	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	60	shown	show	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	61	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	62	be	be	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	63	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	64	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	65	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	45	66	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	1	Our	-PRON-	PRP$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	2	objective	objective	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	3	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	4	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	5	assess	assess	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	6	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	7	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	8	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	9	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	10	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	11	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	12	resource	resource	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	13	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	14	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	15	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	16	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	17	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	18	treated	treat	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	19	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	20	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	21	ZDV	zdv	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	22	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	23	containing	contain	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	24	HAART	HAART	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	25	regimens	regimen	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	46	26	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	1	METHODS	METHODS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	3	Case-	case-	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	4	control	control	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	5	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	6	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	7	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	8	Insight	Insight	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	9	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	10	which	which	WDT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	11	contains	contain	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	12	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	13	chart	chart	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	14	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	15	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	16	21	21	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	17	US	US	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	18	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	19	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	20	centers	center	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	47	21	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	1	ZDV	ZDV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	2	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	3	naïve	naïve	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	4	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	5	who	who	WP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	6	began	begin	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	7	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	8	ZDV	ZDV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	9	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	10	containing	contain	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	11	HAART	HAART	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	12	regimen	regiman	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	13	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	14	any	any	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	15	date	date	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	16	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	17	January	January	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	18	2000	2000	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	19	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	20	June	June	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	21	2004	2004	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	22	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	23	assessed	assess	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	24	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	25	baseline	baseline	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	26	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	27	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	28	Hb	Hb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	29	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	30	11	11	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	31	g	g	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	32	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	33	dL	dL	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	34	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	48	35	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	1	Those	those	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	2	without	without	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	3	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	4	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	5	N	n	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	6	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	7	529	529	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	8	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	9	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	10	followed	follow	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	11	through	through	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	12	June	June	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	14	2005	2005	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	15	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	16	until	until	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	17	they	-PRON-	PRP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	18	had	have	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	19	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	20	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	21	changed	change	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	22	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	23	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	24	non	non	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	25	-	-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	26	ZDV	zdv	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	27	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	28	containing	contain	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	29	regimen	regimen	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	49	30	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	1	Those	those	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	2	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	3	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	4	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	5	N	n	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	6	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	7	69	69	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	8	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	9	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	10	followed	follow	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	11	until	until	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	12	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	13	worsened	worsen	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	14	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	15	drop	drop	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	16	≥	≥	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	17	1.0	1.0	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	18	g	g	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	19	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	20	dL	dL	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	21	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	50	22	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	1	Patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	2	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	3	an	an	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	4	incident	incident	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	5	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	6	event	event	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	7	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	8	initiating	initiate	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	9	or	or	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	10	worsening	worsen	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	11	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	12	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	13	≥12	≥12	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	14	months	month	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	15	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	16	follow	follow	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	17	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	18	up	up	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	19	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	20	selected	select	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	21	as	as	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	22	cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	51	23	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	1	Controls	control	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	2	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	3	matched	match	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	4	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	5	baseline	baseline	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	6	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	7	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	8	CD4	CD4	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	9	<	<	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	10	350	350	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	11	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	12	gender	gender	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	13	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	14	time	time	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	15	period	period	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	52	16	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	1	Medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	2	resource	resource	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	3	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	4	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	5	tabulated	tabulate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	6	during	during	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	7	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	8	1-year	1-year	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	9	post	post	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	10	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	11	period	period	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	53	12	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	1	Costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	2	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	3	estimated	estimate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	4	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	5	health	health	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	6	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	7	encoun-	encoun-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	8	ters	ter	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	9	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	10	external	external	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	11	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	12	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	13	prices	price	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	14	expressed	express	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	15	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	16	2006	2006	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	17	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	18	US	US	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	54	19	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	3	Cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	4	included	include	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	5	70	70	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	6	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	7	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	8	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	9	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	10	57	57	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	11	initiat-	initiat-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	12	ing	ing	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	14	13	13	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	15	worsening	worsen	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	16	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	55	17	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	1	Cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	2	had	have	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	3	greater	great	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	4	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	5	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	6	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	7	resources	resource	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	8	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	9	controls	control	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	10	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	11	9.2	9.2	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	12	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	13	5.0	5.0	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	14	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	15	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	16	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	17	0.001	0.001	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	18	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	19	office	office	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	20	visits	visit	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	21	per	per	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	22	year	year	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	23	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	24	33	33	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	25	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	26	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	27	3	3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	28	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	29	hospitalized	hospitalized	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	30	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	31	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	32	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	33	0.001	0.001	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	34	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	35	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	36	21	21	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	37	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	38	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	39	3	3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	40	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	41	treated	treat	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	42	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	43	EPO	EPO	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	44	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	45	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	46	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	47	0.001	0.001	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	48	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	49	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	50	7	7	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	51	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	52	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	53	0	0	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	54	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	55	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	56	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	57	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	58	0.058	0.058	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	59	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	60	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	61	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	62	transfusion	transfusion	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	56	63	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	1	Cases	case	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	2	had	have	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	3	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	4	average	average	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	5	annual	annual	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	6	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	7	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	8	controls	control	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	9	;	;	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	10	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	11	37,124	37,124	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	12	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	13	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	14	25,141	25,141	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	15	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	16	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	17	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	18	0.002	0.002	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	19	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	57	20	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	1	Cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	2	components	component	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	3	included	include	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	4	EPO	EPO	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	5	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	6	1,369	1,369	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	7	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	8	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	9	181	181	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	10	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	11	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	12	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	13	0.002	0.002	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	14	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	15	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	16	antiretrovirals	antiretroviral	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	17	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	18	18,299	18,299	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	19	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	20	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	21	19,837	19,837	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	22	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	23	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	24	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	25	0.461	0.461	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	26	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	27	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	28	other	other	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	29	drugs	drug	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	30	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	31	12,488	12,488	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	32	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	33	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	34	3,763	3,763	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	35	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	36	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	37	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	38	0.005	0.005	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	39	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	40	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	41	hospital	hospital	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	42	stays	stay	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	43	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	44	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	45	3,114	3,114	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	46	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	47	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	48	169	169	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	49	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	50	P	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	51	<	<	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	52	0.001	0.001	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	53	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	58	54	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	1	CONCLUSION	conclusion	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	3	Patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	4	treated	treat	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	5	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	6	ZDV	ZDV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	7	who	who	WP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	8	experienced	experience	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	9	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	10	required	require	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	11	significantly	significantly	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	12	more	more	RBR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	13	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	14	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	15	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	16	reported	report	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	17	higher	high	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	18	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	19	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	20	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	21	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	22	without	without	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	23	anemia	anemia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	59	24	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	1	PIN26	pin26	LS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	2	IMPACT	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	3	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	4	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	5	AND	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	6	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	7	CO	CO	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	8	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	9	INFECTION	INFECTION	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	10	ON	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	11	HOSPITALIZATION	hospitalization	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	12	AND	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	13	RESOURCE	resource	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	14	USE	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	15	AMONG	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	16	HEMOPHILIA	hemophilia	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	17	ENROLLEES	enrollees	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	18	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	19	COMMERCIAL	commercial	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	20	HEALTH	health	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	21	PLANS	plan	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	22	Tencer	Tencer	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	23	T1	t1	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	24	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	25	Friedman	Friedman	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	26	H2	H2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	27	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	28	Li	Li	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	29	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	30	McLeod	McLeod	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	31	J3	j3	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	32	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	33	Johnson	Johnson	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	34	KA1	KA1	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	35	1University	1University	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	36	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	37	Southern	Southern	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	38	California	California	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	39	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	40	Los	Los	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	41	Angeles	Angeles	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	42	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	43	CA	CA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	44	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	45	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	46	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	47	2Analytic	2Analytic	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	48	Solutions	Solutions	NNPS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	49	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	50	LLC	LLC	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	51	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	52	New	New	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	53	York	York	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	54	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	55	NY	NY	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	56	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	57	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	58	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	59	3Baxter	3Baxter	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	60	BioScience	BioScience	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	61	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	62	Westlake	Westlake	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	63	Village	Village	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	64	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	65	CA	CA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	66	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	67	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	68	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	69	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	70	Determine	determine	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	71	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	72	economic	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	73	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	74	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	75	resource	resource	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	76	uti-	uti-	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	77	lization	lization	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	78	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	79	adult	adult	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	80	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	81	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	82	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	83	co	co	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	84	-	-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	85	infected	infected	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	86	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	87	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	88	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	89	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	90	managed	manage	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	91	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	92	population	population	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	93	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	94	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	95	United	United	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	96	States	States	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	60	97	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	1	METHODS	methods	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	3	Retrospective	retrospective	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	4	claims	claim	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	5	database	database	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	6	analysis	analysis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	7	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	8	1/97	1/97	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	9	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	10	4/04	4/04	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	61	11	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	1	Patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	2	continuously	continuously	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	3	enrolled	enrol	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	4	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	5	at	at	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	6	least	least	RBS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	7	6	6	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	8	months	month	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	9	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	10	>	>	XX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	11	18	18	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	12	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	13	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	14	age	age	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	15	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	16	included	include	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	62	17	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	1	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	2	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	4	identified	identify	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	5	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	6	ICD-9CM	ICD-9CM	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	7	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	8	HCPCS	HCPCS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	9	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	10	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	11	NDC	NDC	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	12	codes	code	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	63	13	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	1	Four	four	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	2	cohorts	cohort	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	3	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	4	analysis	analysis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	5	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	6	established	establish	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	7	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	8	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	9	only	only	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	10	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	11	+	+	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	12	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	14	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	15	+	+	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	16	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	17	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	18	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	19	+	+	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	20	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	21	+	+	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	22	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	64	23	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	2	main	main	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	3	out-	out-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	4	comes	come	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	5	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	6	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	7	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	8	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	9	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	10	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	11	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	12	pharmacy	pharmacy	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	13	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	14	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	15	claims	claim	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	17	inpatient	inpatient	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	18	hospitalizations	hospitalization	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	19	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	20	frequency	frequency	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	21	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	22	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	23	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	24	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	25	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	26	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	27	office	office	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	28	visit	visit	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	29	distribution	distribution	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	30	by	by	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	31	physician	physician	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	32	specialty	specialty	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	65	33	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	3	Annual	annual	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	4	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	5	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	6	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	7	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	8	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	9	85,616	85,616	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	10	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	11	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	12	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	13	only	only	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	14	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	15	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	16	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	17	99,180	99,180	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	18	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	19	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	20	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	21	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	23	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	24	105,676	105,676	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	25	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	26	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	27	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	28	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	29	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	30	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	31	129,889	129,889	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	32	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	33	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	34	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	35	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	36	co	co	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	37	-	-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	38	infected	infected	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	39	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	40	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	41	2004	2004	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	42	dollars	dollar	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	66	43	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	1	Clotting	clotting	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	2	factor	factor	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	3	accounted	account	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	4	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	5	approximately	approximately	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	6	70–81	70–81	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	7	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	8	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	9	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	10	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	67	11	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	2	Hemophilia	Hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	3	only	only	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	4	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	5	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	6	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	7	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	8	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	9	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	10	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	11	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	12	infected	infect	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	13	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	14	cohorts	cohort	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	15	had	have	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	16	prescription	prescription	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	17	drug	drug	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	18	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	19	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	20	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	21	2,341	2,341	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	22	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	23	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	24	8,867	8,867	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	25	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	26	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	27	6,256	6,256	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	28	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	29	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	30	12,060	12,060	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	31	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	32	respectively	respectively	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	68	33	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	1	Approximately	approximately	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	2	17	17	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	3	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	4	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	5	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	6	only	only	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	7	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	8	19	19	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	9	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	11	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	12	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	13	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	14	27	27	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	15	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	16	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	17	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	18	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	19	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	20	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	21	cohorts	cohort	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	22	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	23	hospitalized	hospitalize	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	24	during	during	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	25	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	26	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	27	period	period	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	28	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	29	p	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	30	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	31	0.45	0.45	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	32	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	69	33	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	1	Hospitalizations	hospitalization	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	2	that	that	WDT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	4	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	5	related	relate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	6	accounted	account	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	7	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	8	43	43	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	9	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	11	total	total	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	12	hospitalizations	hospitalization	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	13	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	14	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	15	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	16	only	only	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	17	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	18	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	19	16	16	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	20	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	21	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	22	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	23	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	24	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	25	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	26	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	27	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	28	p	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	29	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	30	0.30	0.30	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	31	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	70	32	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	1	No	no	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	2	significant	significant	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	3	differ-	differ-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	4	ence	ence	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	5	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	6	inpatient	inpatient	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	7	length	length	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	8	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	9	stay	stay	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	10	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	11	found	find	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	71	12	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	1	There	there	EX
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	2	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	3	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	4	differ-	differ-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	5	ence	ence	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	6	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	7	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	8	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	9	number	number	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	11	office	office	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	12	visits	visit	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	13	among	among	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	14	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	15	cohorts	cohort	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	16	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	17	p	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	18	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	19	0.022	0.022	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	20	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	21	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	22	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	23	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	24	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	25	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	26	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	27	having	have	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	28	more	more	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	29	visits	visit	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	30	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	31	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	32	hemophilia	hemophilia	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	33	only	only	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	34	group	group	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	35	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	36	18.3	18.3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	37	vs.	vs.	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	38	7.3	7.3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	39	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	40	respectively	respectively	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	41	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	42	p	p	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	43	=	=	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	44	0.05	0.05	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	45	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	72	46	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	1	CONCLUSION	conclusion	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	3	Although	although	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	4	we	-PRON-	PRP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	5	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	6	not	not	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	7	able	able	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	8	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	9	control	control	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	10	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	11	sever-	sever-	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	12	ity	ity	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	13	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	14	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	15	presence	presence	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	16	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	17	HIV	HIV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	18	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	19	HCV	HCV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	20	co	co	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	21	-	-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	22	infection	infection	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	23	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	24	hemophiliacs	hemophiliacs	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	25	is	be	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	26	associated	associate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	27	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	28	an	an	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	29	increase	increase	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	30	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	31	annual	annual	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	32	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	33	by	by	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	34	up	up	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	35	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	36	52	52	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	37	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	73	38	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	1	Increased	increase	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	2	clotting	clot	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	3	factor	factor	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	4	use	use	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	5	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	6	prescription	prescription	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	7	drug	drug	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	8	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	9	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	10	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	11	virally	virally	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	12	infected	infected	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	13	groups	group	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	14	account	account	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	15	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	16	most	most	JJS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	17	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	18	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	19	increase	increase	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	20	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	21	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	74	22	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	1	PIN27	PIN27	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	2	USING	USING	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	3	DECISION	DECISION	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	4	SIMULATION	SIMULATION	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	5	MODEL	MODEL	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	6	TO	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	7	EVALUATE	EVALUATE	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	8	THE	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	9	COST	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	10	EFFECTIVENESS	effectiveness	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	11	OF	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	12	ENTECAVIR	entecavir	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	13	COMPARED	compare	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	14	TO	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	15	ADEFOVIR	ADEFOVIR	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	16	THERAPY	THERAPY	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	17	IN	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	18	LAMIVUDINE	LAMIVUDINE	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	19	REFRACTORY	REFRACTORY	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	20	CHRONIC	CHRONIC	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	21	HEPATITIS	HEPATITIS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	22	B	B	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	23	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	24	CHB	CHB	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	25	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	26	PATIENTS	PATIENTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	27	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	28	ANALYSES	analysis	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	29	FROM	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	30	A	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	31	US	US	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	32	PAYER	payer	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	33	PERSPECTIVE	perspective	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	34	Yuan	yuan	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	35	Y1	y1	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	37	Iloeje	Iloeje	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	38	U2	U2	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	39	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	40	Parry	Parry	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	41	D3	D3	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	42	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	43	Hay	Hay	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	44	JW4	JW4	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	45	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	46	Zammit	Zammit	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	47	D5	D5	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	48	1Bristol	1Bristol	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	49	Myers	Myers	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	50	Squibb	Squibb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	51	International	International	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	52	Corporation	Corporation	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	53	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	54	Plainsboro	Plainsboro	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	55	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	56	NJ	NJ	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	57	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	58	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	59	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	60	2Bristol	2Bristol	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	61	Myers	Myers	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	62	Squibb	Squibb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	63	Company	Company	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	64	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	65	Wallingford	Wallingford	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	66	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	67	CT	CT	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	68	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	69	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	70	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	71	3Bristol	3Bristol	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	72	Myer	Myer	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	73	Squibb	Squibb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	74	Company	Company	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	75	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	76	Hounslow	Hounslow	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	77	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	78	Middlesex	Middlesex	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	79	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	80	UK	UK	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	81	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	82	4University	4university	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	83	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	84	Southern	Southern	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	85	California	California	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	86	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	87	Los	Los	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	88	Angeles	Angeles	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	89	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	90	CA	CA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	91	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	92	USA	USA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	93	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	94	5Bristol	5Bristol	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	95	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	96	Myers	Myers	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	97	Squibb	Squibb	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	98	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	99	Braine	Braine	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	100	l’Alleud	l’Alleud	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	101	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	102	Belgium	Belgium	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	103	OBJECTIVES	OBJECTIVES	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	104	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	105	To	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	106	estimate	estimate	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	107	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	108	long	long	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	109	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	110	term	term	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	111	health	health	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	112	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	113	economic	economic	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	114	impact	impact	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	115	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	116	managing	manage	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	117	CHB	CHB	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	118	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	119	entecavir	entecavir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	120	instead	instead	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	121	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	122	adefovir	adefovir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	123	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	124	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	125	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	126	US	US	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	127	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	128	based	base	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	129	upon	upon	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	130	projected	project	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	131	clinical	clinical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	132	benefits	benefit	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	133	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	134	HBV	HBV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	135	DNA	DNA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	136	reduction	reduction	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	137	observed	observe	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	138	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	139	trials	trial	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	75	140	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	1	METHODS	methods	LS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	3	We	-PRON-	PRP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	4	took	take	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	5	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	6	perspective	perspective	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	7	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	8	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	9	comprehensive	comprehensive	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	10	payer	payer	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	11	responsible	responsible	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	12	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	13	all	all	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	14	direct	direct	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	15	health	health	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	16	care	care	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	17	expenditures	expenditure	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	76	18	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	1	A	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	2	decision	decision	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	3	simulation	simulation	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	4	model	model	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	5	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	6	developed	develop	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	7	to	to	TO
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	8	consider	consider	VB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	9	a	a	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	10	hypothetical	hypothetical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	11	cohort	cohort	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	12	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	13	1000	1000	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	14	lamivudine	lamivudine	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	15	refractory	refractory	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	16	CHB	CHB	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	17	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	77	18	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	1	Multivariate	multivariate	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	2	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	3	adjusted	adjust	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	4	relative	relative	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	5	risks	risk	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	6	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	7	five	five	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	8	HBV	HBV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	9	DNA	DNA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	10	categories	category	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	11	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	12	derived	derive	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	13	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	14	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	15	published	publish	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	16	R.E.V.E.A.L.-HBV	R.E.V.E.A.L.-HBV	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	17	study	study	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	78	18	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	1	These	these	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	2	results	result	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	3	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	4	applied	apply	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	5	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	6	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	7	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	8	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	9	simulation	simulation	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	10	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	11	their	-PRON-	PRP$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	12	HBV	HBV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	13	DNA	DNA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	14	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	15	derived	derive	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	16	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	17	summary	summary	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	18	statistics	statistic	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	19	reported	report	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	20	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	21	separate	separate	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	22	entecavir	entecavir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	23	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	24	adefovir	adefovir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	25	clinical	clinical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	26	trials	trial	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	79	27	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	1	Entecavir	Entecavir	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	2	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	3	Adefovir	adefovir	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	4	daily	daily	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	5	costs	cost	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	6	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	7	assumed	assume	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	8	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	9	20.52	20.52	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	10	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	11	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	12	19.11	19.11	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	13	based	base	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	14	on	on	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	15	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	16	wholesale	wholesale	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	17	acquisition	acquisition	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	18	prices	price	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	80	19	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	1	Life	life	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	2	expectancy	expectancy	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	3	estimates	estimate	VBZ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	4	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	5	direct	direct	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	6	medical	medical	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	7	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	8	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	9	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	10	utility	utility	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	11	scores	score	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	12	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	13	different	different	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	14	phases	phase	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	15	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	16	CHB	CHB	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	17	were	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	18	estimated	estimate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	19	from	from	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	20	pub-	pub-	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	21	lished	lishe	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	22	US	US	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	23	specific	specific	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	24	data	datum	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	81	25	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	1	Viral	viral	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	2	resistance	resistance	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	3	due	due	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	4	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	5	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	6	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	7	included	include	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	82	8	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	1	RESULTS	RESULTS	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	2	:	:	:
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	3	Entecavir	Entecavir	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	4	was	be	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	5	superior	superior	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	6	to	to	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	7	adefovir	adefovir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	8	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	9	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	10	mean	mean	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	11	reduction	reduction	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	12	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	13	serum	serum	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	14	HBV	HBV	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	15	DNA	DNA	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	16	by	by	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	17	PCR	PCR	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	18	assay	assay	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	19	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	20	log10	log10	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	21	copies	copies	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	22	/	/	SYM
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	23	mL	mL	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	24	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	25	adjusted	adjust	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	26	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	27	lamivudine	lamivudine	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	28	effect	effect	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	29	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	30	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	31	reductions	reduction	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	32	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	33	4.97	4.97	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	34	versus	versus	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	35	4.00	4.00	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	37	respectively	respectively	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	83	38	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	1	More	More	JJR
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	2	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	3	reached	reach	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	4	unde-	unde-	RB
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	5	tectable	tectable	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	6	viral	viral	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	7	load	load	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	8	level	level	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	9	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	10	entecavir	entecavir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	11	than	than	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	12	adefovir	adefovir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	13	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	14	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	15	Week	week	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	16	48	48	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	17	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	18	19.5	19.5	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	19	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	20	vs	vs	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	21	9.6	9.6	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	22	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	23	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	84	24	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	1	In	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	2	the	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	3	reference	reference	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	4	case	case	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	5	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	6	for	for	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	7	1000	1000	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	8	patients	patient	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	9	aged	age	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	10	40	40	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	11	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	12	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	13	compared	compare	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	14	with	with	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	15	adefovir	adefovir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	16	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	17	ten	ten	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	18	years	year	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	19	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	20	ente-	ente-	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	21	cavir	cavir	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	22	treatment	treatment	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	23	avoided	avoid	VBD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	24	25	25	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	25	compensated	compensate	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	26	cirrhosis	cirrhosis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	27	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	28	3	3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	29	decompen-	decompen-	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	30	sated	sated	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	31	cirrhosis	cirrhosis	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	32	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	33	and	and	CC
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	34	15	15	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	35	HCC	HCC	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	36	,	,	,
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	37	resulting	result	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	38	in	in	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	39	0.235	0.235	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	40	quality	quality	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	41	-	-	HYPH
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	42	adjusted	adjust	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	43	life	life	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	44	year	year	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	45	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	46	QALY	QALY	NNP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	47	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	48	gain	gain	VBP
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	49	at	at	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	50	an	an	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	51	incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	52	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	53	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	54	$	$	$
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	55	2563	2563	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	56	per	per	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	57	patient	patient	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	58	(	(	-LRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	59	3	3	CD
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	60	%	%	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	61	discounted	discount	VBN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	62	)	)	-RRB-
work_3qtgbd6zv5cp3oxsj4ydrr56tu	85	63	.	.	.
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	1	The	the	DT
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	2	incremental	incremental	JJ
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	3	cost	cost	NN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	4	of	of	IN
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	5	using	use	VBG
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	6	entecavir	entecavir	NNS
work_3qtgbd6zv5cp3oxsj4ydrr56tu	86	7	was	be	VBD